Enliven Therapeutics (ELVN) Prepaid Assets (2019 - 2026)

Enliven Therapeutics has disclosed Prepaid Assets across 8 years of filings, most recently posting $10.7 million for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $10.7 million, up 125.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.7 million (up 125.4% YoY), and the FY2025 annual result was $12.3 million, up 164.56% from the prior year.
• Prepaid Assets came in at $10.7 million for Q1 2026 at Enliven Therapeutics, down from $12.3 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $12.3 million in Q4 2025 to a low of $2.2 million in Q4 2022.
• The 5-year median for Prepaid Assets is $5.1 million (2025), against an average of $5.5 million.
• Peak annual rise in Prepaid Assets reached 164.56% in 2025, while the deepest fall reached 28.28% in 2025.
• Enliven Therapeutics' Prepaid Assets stood at $2.2 million in 2022, then surged by 33.02% to $2.9 million in 2023, then soared by 57.1% to $4.6 million in 2024, then surged by 164.56% to $12.3 million in 2025, then retreated by 12.41% to $10.7 million in 2026.
• The last three Prepaid Assets figures came in at $10.7 million (Q1 2026), $12.3 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.